The Duty of Care Employers Owe Medical Cannabis Patients Copy
Employers do not need a bespoke cannabis policy, their existing medicines, disability and occupational health processes should be applied.
24 results for “patients”
Employers do not need a bespoke cannabis policy, their existing medicines, disability and occupational health processes should be applied.
Devon Partnership NHS Trust has approved procedures for patients to continue taking their prescribed cannabis-based medications while in hospital.
Since launching its legal support helpline, Releaf Cannabis Clinic has received increasing reports from patients experiencing stigma and discrimination.
Medical cannabis patients are often framed as consumers chasing the next strain, but that overlooks how many navigate treatment, writes Dave Barton.
Medical cannabis has been legal in the UK since 2018, but for many patients, taking or carrying their prescribed medication in public still comes with uncertainty. Since launching its legal […]
In a new multi-clinic survey, the majority of patients report improvements in their symptoms.
The guide aims to help patients travel safely, confidently, and within the law.
A survey of more than 3,500 patients in Germany found that more than half were able to reduce their use of other medications.
The party has passed a motion that aims to protect patients from discrimination related to their use of prescribed cannabis medicines.
A small pilot study suggests Epidiolex may have benefits for weight restoration and symptom improvement in anorexia patients.
By Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic In her bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf […]
A new UK-wide service has launched to support medical cannabis patients who face discrimination.
Last week, the first official guidance on medical cannabis for police officers in England and Wales was made public.
The company is preparing to reach a major regulatory milestone and bring its lead product to market in early 2026.
Seven years after medical cannabis was legalised in the UK, new data from Releaf sheds light on how the treatment is changing patients’ lives, but also where progress is still […]
The event brought together expert medical and scientific voices and powerful patient perspectives.
Findings highlighting the relationship between trauma, THC and paranoia have prompted calls for improved patient monitoring.
Almost seven years since medical cannabis was legalised in the UK on 1st November 2018, less than 1% of the UK’s approximate 100,000 doctors on the General Medical Council (GMC) […]
The international patient-led organisation We, The Patients, will bring its educational series to London next month.
Dr Sue Clenton, Medical Director of Releaf cannabis clinic explains what it takes to go from a few hundred to thousands of patients, without compromising on the quality of care. […]
The conversation around workers’ rights and medical cannabis is still at a very early stage in the UK.
Curaleaf Laboratories, part of Curaleaf International, today announced the UK launch of the Curaleaf Que Medical Inhalation Device (QMID), the first CE-certified liquid inhaler for cannabis-based medicines. Available on prescription, […]
A substantial number of patients’ details, including prescription information, were found on a file hosting website.
Campaigners are urging lawmakers to consider the challenges facing people who rely on access for medical purposes.